EU regulator backs use of GSK's RSV shot in adults aged 50 to 59
The European Union health regulator on Friday recommended expanded use of GSK's respiratory syncytial virus (RSV) vaccine in adults aged between 50 and 59.
July 26, 2024The European Union health regulator on Friday recommended expanded use of GSK's respiratory syncytial virus (RSV) vaccine in adults aged between 50 and 59.
July 26, 2024Shares of Pfizer and German partner BioNTech fell on Monday after the U.S. drugmaker slashed the sales forecast for its COVID vaccine and therapy last week, and some
April 26, 2024Moderna on Thursday reported a surprise fourth-quarter profit helped by cost cutting and some deferred payments, and the vaccine maker set out a
April 26, 2024Malaria is still a significant public health challenge in Kenya, but an important pilot of the world’s first malaria vaccine may help
April 25, 2024The World Health Organization has authorized a second dengue vaccine, a move that could provide protection for millions worldwide against the mosquito-borne disease that has already sparked numerous outbreaks across the Americas this year
May 15, 2024Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has started manufacturing that targets a variant
June 11, 2024US government inks a deal with Moderna to make pandemic flu vaccine
July 02, 2024Health workers in Ivory Coast have begun giving children the latest malaria vaccine
July 15, 2024Robert Langer, co-founder and a key figure behind Moderna's scientific success, will step down from the vaccine maker's board on Aug. 5, the company said on Tuesday.
July 23, 2024